Replies to post #333628 on Innovation Pharmaceuticals Inc (IPIX)

[Justfactsmam]

Familyman stated: "...mind-blowingly crucial data because it became available one week too late?!?! Unbelievable!!!"

Welcome to "The Bureaucracy"...contrary to KFCyahoo's response implying Leo controlled the RBL reporting results to IPIX (which he did and does not) and the deadline for the rolling grant review passed.  But fret NOT...the grant application roles over to the next period and deadline...so my understanding is that the data information (and more) is in the next grant period for review. 

Blaming Leo for RBL delays in assembling and releasing data which IPIX has/had no control over is a non-starter...pure BS.   Of course, you won't hear from the same critic(s) throwing accolades in Leo's direction for submitting applications for Brilacidin's regulatory approval in two jurisdictions (U.S. and "Overseas").
  
Regarding IND...PR clearly states IPIX was complying with minor comments made by FDA re: IND application ...so IMO the answer is clearly YES: "...IPIX has been packaged the trial format the way FDA wants it."...and now we wait the 30 days. ... meanwhile IPIX has application in "overseas" jurisdiction for Human Clinical Trials for  drug approval in that jurisdiction, which CT results will also be used in the U.S.

In the end..with Leo's strategy...IF INTENTIONAL DELAY...by FDA...after stellar results in Trials in U.S. and Russia and Russia's approval...FDA will have serious egg on its face and support a huge FOX New and FOX Business News campaign. 

Meanwhile on the vaccine front PFE and Moderna are locked in "ONE UP ON YOU" trying to push the envelope on representations of efficacy....but SAFETY is far from settled. 

IMO...discussion about AlfaSigma is a non-starter...because they are a non-starter with Brilacidin and likely default in its licensing agreement and return it back all of its rights under their limited licensed B-UP...good for IPIX.

With successful "overseas" trials and emergency approval...even without U.S. regulatory movement...YES, Kingofsting...IPIX can hit $5.00 by March.